What is the clinical evidence from this study?

Study design: Case Report. Population: Primary adrenal non-Hodgkin lymphoma (n=1). Intervention: Left adrenalectomy and CHOP chemotherapy. Primary outcome: Metabolic response.

April 12, 2017Journal of Medical Case ReportsOpen Access

A 50-year-old man with primary adrenal diffuse large B-cell lymphoma achieved a complete metabolic response following left adrenalectomy and six cycles of CHOP chemotherapy.

View Full Paper

Ask AI

Bookmark

Population

1 50-year-old Pakistani man with primary left adrenal diffuse large B-cell lymphoma and a 21-year history of…

Design

Case_report

Key result

A 50-year-old man with primary adrenal diffuse large B-cell lymphoma achieved a complete metabolic response following left adrenalectomy and six cycles of CHOP chemotherapy.

Authors

NRNanik Ram OROwais Rashid SFSaad Farooq

Discussion

Member takes

Overview

May support adrenalectomy plus CHOP in primary adrenal DLBCL; leaves open need for prospective validation.

Study Design

Type

Case Report (n=1)

Multicenter

Structured PICO

Population

A 50-year-old man with primary left adrenal diffuse large B-cell lymphoma who underwent adrenalectomy and CHOP chemotherapy.

Intervention

Left adrenalectomy followed by 6 cycles of CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone).

Outcome

Clinical and metabolic response to treatment.

Primary adrenal diffuse large B-cell lymphoma can be successfully treated with adrenalectomy and CHOP chemotherapy, achieving complete metabolic response even without rituximab.

Limitations

Optimal treatment protocol has not yet been established
Single case report limits generalizability

Cite This Study

Ram et al. (2017) conducted a case report in Primary adrenal non-Hodgkin lymphoma (n=1). Left adrenalectomy and CHOP chemotherapy was evaluated on Metabolic response. A 50-year-old man with primary adrenal diffuse large B-cell lymphoma achieved a complete metabolic response following left adrenalectomy and six cycles of CHOP chemotherapy.

synapsesocial.com/papers/6a6f236a75498292b708884a https://doi.org/10.1186/s13256-017-1271-x

View Full Paper

Ask AI

Bookmark

April 12, 2017Journal of Medical Case ReportsOpen Access

A 50-year-old man with primary adrenal diffuse large B-cell lymphoma achieved a complete metabolic response following left adrenalectomy and six cycles of CHOP chemotherapy.

View Full Paper

Ask AI

Bookmark

Population

1 50-year-old Pakistani man with primary left adrenal diffuse large B-cell lymphoma and a 21-year history of…

Design

Case_report

Key result

A 50-year-old man with primary adrenal diffuse large B-cell lymphoma achieved a complete metabolic response following left adrenalectomy and six cycles of CHOP chemotherapy.

Authors

NRNanik Ram OROwais Rashid SFSaad Farooq

Discussion

Member takes

Overview

May support adrenalectomy plus CHOP in primary adrenal DLBCL; leaves open need for prospective validation.

Study Design

Type

Case Report (n=1)

Multicenter

Structured PICO

Population

A 50-year-old man with primary left adrenal diffuse large B-cell lymphoma who underwent adrenalectomy and CHOP chemotherapy.

Intervention

Left adrenalectomy followed by 6 cycles of CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone).

Outcome

Clinical and metabolic response to treatment.

Primary adrenal diffuse large B-cell lymphoma can be successfully treated with adrenalectomy and CHOP chemotherapy, achieving complete metabolic response even without rituximab.

Limitations

Optimal treatment protocol has not yet been established
Single case report limits generalizability

Cite This Study

synapsesocial.com/papers/6a6f236a75498292b708884a https://doi.org/10.1186/s13256-017-1271-x

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark